ISHL12 | The effect of heart failure on the management and outcomes of older patients with Hodgkin lymphoma
Jenica Upshaw
• 19 Oct 2022
Jenica Upshaw, MD, Tufts University, Boston, MA, shares the findings of a study which investigated the effect of heart failure on the management and outcomes of older patients with Hodgkin lymphoma (HL), and further comments on how the risk of heart failure in these patients may be reduced with the use of medications such as liposomal doxorubicin. This interview took place at The 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
